Skip to main content
Published Online:https://doi.org/10.3928/23258160-20210302-01Cited by:1

Abstract

BACKGROUND AND OBJECTIVE:

To quantify fractal dimension (FD) by mass-radius method in optical coherence tomography angiography (OCTA) images and characterize microvascular differences in eyes with and without diabetic retinopathy (DR).

PATIENTS AND METHODS:

A retrospective study was conducted using OCTA images of 3 mm × 3 mm and 6 mm × 6 mm scans for superficial and deep capillary plexuses from 49 control eyes and 58 eyes with DR.

RESULTS:

Analysis of variance showed a significant difference between the FD of control and diabetic eyes in deep plexus scans, and the 3 mm × 3 mm superficial plexus scan (P < .05). In the 3 mm × 3 mm superficial plexus, the FD of severe nonproliferative DR (NPDR) and proliferative DR (PDR) were significantly lower compared to control. The scans of the deep plexus showed only severe NPDR was significantly reduced in the 6 mm × 6 mm scan, whereas moderate NPDR, severe NPDR, and PDR were significantly lower in the 3 mm × 3 mm scan.

CONCLUSION:

The study suggests the use of FD as a measure of microvascular dropout in DR.

[Ophthalmic Surg Lasers Imaging Retina. 2021;52:116–122.]

  • 1.Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010; 376(9735):124–136. 10.1016/S0140-6736(09)62124-3 PMID:20580421

    Crossref MedlineGoogle Scholar
  • 2.Cho NH, Shaw JE, Karuranga Set al.. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271–281. 10.1016/j.diabres.2018.02.023 PMID:29496507

    Crossref MedlineGoogle Scholar
  • 3.Wong TY, Cheung CM, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nat Rev Dis Primers. 2016; 2(1):16012. 10.1038/nrdp.2016.12 PMID:27159554

    Crossref MedlineGoogle Scholar
  • 4.Wong TY, Sun J, Kawasaki Ret al.. Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. Ophthalmology. 2018; 125(10):1608–1622. 10.1016/j.ophtha.2018.04.007 PMID:29776671

    Crossref MedlineGoogle Scholar
  • 5.Hartnett ME, Baehr W, Le YZ. Diabetic retinopathy, an overview. Vision Res. 2017; 139:1–6. 10.1016/j.visres.2017.07.006 PMID:28757399

    Crossref MedlineGoogle Scholar
  • 6.Safi H, Safi S, Hafezi-Moghadam A, Ahmadieh H. Early detection of diabetic retinopathy. Surv Ophthalmol. 2018; 63(5):601–608. 10.1016/j.survophthal.2018.04.003 PMID:29679616

    Crossref MedlineGoogle Scholar
  • 7.Frank RN. Diabetic retinopathy. N Engl J Med. 2004; 350(1):48–58. 10.1056/NEJMra021678 PMID:14702427

    Crossref MedlineGoogle Scholar
  • 8.Goebel W, Franke R. Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina. 2006; 26(1):49–57. 10.1097/00006982-200601000-00009 PMID:16395139

    Crossref MedlineGoogle Scholar
  • 9.Virgili G, Menchini F, Casazza Get al.. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev. 2015; 1:CD008081. 10.1002/14651858.CD008081.pub3 PMID:25564068

    Crossref MedlineGoogle Scholar
  • 10.Gildea D. The diagnostic value of optical coherence tomography angiography in diabetic retinopathy: a systematic review. Int Ophthalmol. 2019; 39(10):2413–2433. 10.1007/s10792-018-1034-8 PMID:30382465

    Crossref MedlineGoogle Scholar
  • 11.Khadamy J, Abri Aghdam K, Falavarjani KG. An Update on Optical Coherence Tomography Angiography in Diabetic Retinopathy. J Ophthalmic Vis Res. 2018; 13(4):487–497. 10.4103/jovr.jovr_57_18 PMID:30479720

    Crossref MedlineGoogle Scholar
  • 12.Hwang TS, Jia Y, Gao SSet al.. Optical Coherence Tomography Angiography Features of Diabetic Retinopathy. Retina. 2015; 35(11):2371–2376. 10.1097/IAE.0000000000000716 PMID:26308529

    Crossref MedlineGoogle Scholar
  • 13.Ashraf M, Nesper PL, Jampol LM, Yu F, Fawzi AA. Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2018; 59(10):4292–4298. 10.1167/iovs.18-24142 PMID:30167660

    Crossref MedlineGoogle Scholar
  • 14.Ţălu Ş, Călugăru DM, Lupaşcu CA. Characterisation of human nonproliferative diabetic retinopathy using the fractal analysis. Int J Ophthalmol. 2015; 8(4):770–776. PMID:26309878

    MedlineGoogle Scholar
  • 15.Bhardwaj S, Tsui E, Zahid Set al.. Value of Fractal Analysis of Optical Coherence Tomography Angiography in Various Stages of Diabetic Retinopathy. Retina. 2018; 38(9):1816–1823. 10.1097/IAE.0000000000001774 PMID:28723846

    Crossref MedlineGoogle Scholar
  • 16.Zahid S, Dolz-Marco R, Freund KBet al.. Fractal Dimensional Analysis of Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2016; 57(11):4940–4947. 10.1167/iovs.16-19656 PMID:27654421

    Crossref MedlineGoogle Scholar
  • 17.Landini G, Rippin JW. Notes on the implementation of the mass-radius method of fractal dimension estimation. Comput Appl Biosci. 1993; 9(5):547–550. 10.1093/bioinformatics/9.5.547 PMID:8293328

    Crossref MedlineGoogle Scholar
  • 18.Avakian A, Kalina RE, Sage EHet al.. Fractal analysis of region-based vascular change in the normal and non-proliferative diabetic retina. Curr Eye Res. 2002; 24(4):274–280. 10.1076/ceyr.24.4.274.8411 PMID:12324866

    Crossref MedlineGoogle Scholar
  • 19.Lee J, Zee BC, Li Q. Detection of neovascularization based on fractal and texture analysis with interaction effects in diabetic retinopathy. PLoS One. 2013; 8(12):e75699. 10.1371/journal.pone.0075699 PMID:24358105

    Crossref MedlineGoogle Scholar
  • 20.Daxer A. Characterisation of the neovascularisation process in diabetic retinopathy by means of fractal geometry: diagnostic implications. Graefes Arch Clin Exp Ophthalmol. 1993; 231(12):681–686. 10.1007/BF00919281 PMID:8299974

    Crossref MedlineGoogle Scholar
  • 21.Daxer A. The fractal geometry of proliferative diabetic retinopathy: implications for the diagnosis and the process of retinal vasculogenesis. Curr Eye Res. 1993; 12(12):1103–1109. 10.3109/02713689309033508 PMID:8137633

    Crossref MedlineGoogle Scholar
  • 22.Spaide RF, Klancnik JM, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015; 133(1):45–50. 10.1001/jamaophthalmol.2014.3616 PMID:25317632

    Crossref MedlineGoogle Scholar
  • 23.Agemy SA, Scripsema NK, Shah CMet al.. Retinal Vascular Perfusion Density Mapping Using Optical Coherence Tomography Angiography in Normals and Diabetic Retinopathy Patients. Retina. 2015; 35(11):2353–2363. 10.1097/IAE.0000000000000862 PMID:26465617

    Crossref MedlineGoogle Scholar
  • 24.Dupas B, Minvielle W, Bonnin Set al.. Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes. JAMA Ophthalmol. 2018; 136(7):721–728. 10.1001/jamaophthalmol.2018.1319 PMID:29800967

    Crossref MedlineGoogle Scholar
  • 25.Bek T. Transretinal histopathological changes in capillary-free areas of diabetic retinopathy. Acta Ophthalmol (Copenh). 1994; 72(4):409–415. 10.1111/j.1755-3768.1994.tb02787.x PMID:7825403

    Crossref MedlineGoogle Scholar

We use cookies on this site to enhance your user experience. For a complete overview of all the cookies used, please see our privacy policy.

×